Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Conway

Showing results (131-140 of 166) with videos related to

Pageof 17
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 23, 2023
Preventing infections in immunocompromised patients with kidney diseases: vaccines and antimicrobial prophylaxisMartin Windpessl, Myrto Kostopoulou, Richard Conway, et al.
Rheumatology Advances in Practice|November 26, 2024
CONTExT-RA: a cross-sectional study evaluating disease activity, quality of life and the socio-demographic profile of Irish patients with rheumatoid arthritisGrainne Murphy, Killian O'Rourke, Angela Camon, et al.
Seminars in Arthritis and Rheumatism|May 20, 2018
Ustekinumab for refractory giant cell arteritis: A prospective 52-week trialRichard Conway, Lorraine O'Neill, Phil Gallagher, et al.
Open Access Rheumatology : Research and Reviews|March 24, 2017
Long-term safety and efficacy of biosimilar infliximab among patients with inflammatory arthritis switched from reference productAbuelmagd Abdalla, Niamh Byrne, Richard Conway, et al.
The Journal of Rheumatology|January 2, 2022
Dr. Conway et al replyRichard Conway, Elisabeth Brouwer, Kornelis S M van der Geest, et al.
Annals of the Rheumatic Diseases|May 5, 2016
Ustekinumab for the treatment of refractory giant cell arteritisRichard Conway, Lorraine O'Neill, Eileen O'Flynn, et al.
The Journal of Rheumatology|October 16, 2020
Giant Cell Arteritis and COVID-19: Similarities and Discriminators. A Systematic Literature ReviewPuja Mehta, Sebastian E Sattui, Kornelis S M van der Geest, et al.
Stroke|October 26, 2018
Diagnostic Utility of Computed Tomographic Angiography in Giant-Cell ArteritisRichard Conway, Anna E Smyth, Richard G Kavanagh, et al.
Clinical and Experimental Rheumatology|January 9, 2019
Performance characteristics and predictors of temporal artery ultrasound for the diagnosis of giant cell arteritis in routine clinical practice in a prospective cohortRichard Conway, Lorraine O'Neill, Geraldine M McCarthy, et al.
Annals of the Rheumatic Diseases|August 12, 2018
Interleukin 12 and interleukin 23 play key pathogenic roles in inflammatory and proliferative pathways in giant cell arteritisRichard Conway, Lorraine O'Neill, Geraldine M McCarthy, et al.
Pageof 17

Showing results (131-140 of 166) with videos related to

Sort By:
Pageof 17
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 23, 2023
Preventing infections in immunocompromised patients with kidney diseases: vaccines and antimicrobial prophylaxisMartin Windpessl, Myrto Kostopoulou, Richard Conway, et al.
Rheumatology Advances in Practice|November 26, 2024
CONTExT-RA: a cross-sectional study evaluating disease activity, quality of life and the socio-demographic profile of Irish patients with rheumatoid arthritisGrainne Murphy, Killian O'Rourke, Angela Camon, et al.
Seminars in Arthritis and Rheumatism|May 20, 2018
Ustekinumab for refractory giant cell arteritis: A prospective 52-week trialRichard Conway, Lorraine O'Neill, Phil Gallagher, et al.
Open Access Rheumatology : Research and Reviews|March 24, 2017
Long-term safety and efficacy of biosimilar infliximab among patients with inflammatory arthritis switched from reference productAbuelmagd Abdalla, Niamh Byrne, Richard Conway, et al.
The Journal of Rheumatology|January 2, 2022
Dr. Conway et al replyRichard Conway, Elisabeth Brouwer, Kornelis S M van der Geest, et al.
Annals of the Rheumatic Diseases|May 5, 2016
Ustekinumab for the treatment of refractory giant cell arteritisRichard Conway, Lorraine O'Neill, Eileen O'Flynn, et al.
The Journal of Rheumatology|October 16, 2020
Giant Cell Arteritis and COVID-19: Similarities and Discriminators. A Systematic Literature ReviewPuja Mehta, Sebastian E Sattui, Kornelis S M van der Geest, et al.
Stroke|October 26, 2018
Diagnostic Utility of Computed Tomographic Angiography in Giant-Cell ArteritisRichard Conway, Anna E Smyth, Richard G Kavanagh, et al.
Clinical and Experimental Rheumatology|January 9, 2019
Performance characteristics and predictors of temporal artery ultrasound for the diagnosis of giant cell arteritis in routine clinical practice in a prospective cohortRichard Conway, Lorraine O'Neill, Geraldine M McCarthy, et al.
Annals of the Rheumatic Diseases|August 12, 2018
Interleukin 12 and interleukin 23 play key pathogenic roles in inflammatory and proliferative pathways in giant cell arteritisRichard Conway, Lorraine O'Neill, Geraldine M McCarthy, et al.
Pageof 17